Berlin, Germany

Alfred Pauls

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Schering Aktiengesellschaft. Active years: 1997.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alfred Pauls - Innovator in Dermal Applications

Introduction

Alfred Pauls is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of dermatology through his innovative work on prostacyclin derivatives. His research focuses on developing effective treatments for skin disorders, particularly those caused by arterial occlusive diseases.

Latest Patents

Alfred Pauls holds a patent for "Agents containing prostacyclin derivatives for topical application." This invention relates to a dermal application form of prostacyclin derivatives, which are designed to treat ulcerations and other skin disorders. The patent outlines a complex formula that includes various chemical components, ensuring the effectiveness of the treatment.

Career Highlights

Throughout his career, Alfred Pauls has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work has led to advancements in topical treatments, showcasing his dedication to improving patient care through innovative solutions.

Collaborations

Alfred has collaborated with notable colleagues, including Roland Ekerdt and Georg Raptis. These partnerships have contributed to the development of his patented technologies and have enhanced the research efforts within his field.

Conclusion

Alfred Pauls is a distinguished inventor whose work in prostacyclin derivatives has the potential to significantly impact dermatological treatments. His contributions reflect a commitment to innovation and improving health outcomes for patients with skin disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…